Sexually Transmitted Diseases · 2006 · 24 citations · 42 references
Public HealthCommunity HealthInfectious DiseasesHiv PreventionInfectious Disease EpidemiologyReproductive HealthHiv DiagnosisHiv EpidemiologyHiv TestingSexual HealthSexually Transmitted InfectionsCross-sectional EpidemiologyDemographic Data ExtractionHiv Transmission DynamicsInfection Risk FactorsInjecting Drug UseTransmission Risk Factors
In Brief Objective: The objective of this study was to ascertain the prevalence and to investigate risk factors for human T lymphotropic virus type I/II (HTLV I/II) infection among subjects who tested for HIV at three counseling centers in Porto Alegre, Brazil. Methods: The authors conducted a cross-sectional study in which subjects screened for HIV were tested for HTLV. Socioeconomic and demographic data, social and sexual behavior, history of having been breastfed, and past blood transfusion or drug use were gathered with a standardized questionnaire. Results: Among 2985 participants, 2.4% had HTLV infection confirmed (1.4% HTLV I). The risk increased with age, but there was no difference among genders. The multivariate model shows that injecting cocaine users were 5.2 (95% confidence interval, 2.5–10.7) times more likely to be HTLV I/II-positive than noninjecting cocaine users and HIV infection persisted as an independent risk factor. Conclusion: Among persons presenting at HIV testing centers in Porto Alegre, Brazil, HTLV I was three times more common than HTLV II; injection drug use was the predominant mode of transmission. A cross-sectional study carried in Southern Brazil found that of participants with HIV infection 8.2% were coinfected by human T lymphotropic virus type I/II and the use of any illicit drug was the predominant mode of transmission.
42
Bernard J. Poiesz, Francis W. Ruscetti, Adi F. Gazdar et al. · Proceedings of the National Academy of Sciences · 1980 · 5.1K citations · Full text
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Antoine Gessain, J C Vernant, L. Maurs et al. · The Lancet · 1985 · 2.9K citations